We report here on the first case, to our knowledge, of retro-odontoid pseudotumor (ROP) in a patient with an autoimmune disease other than rheumatoid arthritis (RA). It is possible that the onset of ROP was related to Sjögren syndrome (SS) with serology for systemic lupus erythematosus (SLE).
A 34-year-old man presented with an ROP without RA. Three years earlier, he had sicca symptoms and many renal and splenic infarctions, and was diagnosed with SS and antiphospholipid antibody syndrome. The anti-SSA, anti-SSB, anti-dsDNA, anti-RNP, and anti-Sm antibodies and lupus anticoagulant were positive, with low C4 level, meeting the European League Against Rheumatism/American College of Rheumatology 2017 draft of the classification criteria for SLE. The patient was treated with warfarin. Recently he had occipital headaches; cerebrospinal fluid analysis and brain magnetic resonance imaging (MRI) were normal. A mass demonstrated on cervical MRI had the typical image of an ROP (Figure 1). We also suspected tension headaches. The pain was gradually alleviated with loxoprofen sodium.
ROP are occasionally caused by RA, atlantoaxial subluxation, amyloid deposits from dialysis, spondylosis, or ossification of the anterior longitudinal ligament. Degenerative changes in the cervical spine or ligament ossification cause immobility and instability of the cervical spines that result in pseudotumor formation1. No degenerative changes were apparent on dynamic radiograph or computed tomography images (Figure 2). Epidemiologically, ROP increase with age2. In cases without the aforementioned background, the youngest reported patient, based on our PubMed search, was 55 years old3. Our patient was 34 years old; thus it was difficult to account for an ROP due to age alone.
There have been no ROP cases in patients with autoimmune diseases other than RA, to our knowledge. We report here the possibility that the onset of ROP was related to SS with SLE serology.
Footnotes
Keishi Fujio received financial support or fees from Astellas, BMS, MitsubishiTanabe, Eli Lilly, Pfizer, Santen, Takeda, Chugai, Eisai, Taisho Toyama, NihonKayaku, and UCB. Ethical approval not required for case reports, according to the policy of the University of Tokyo. Written informed consent was obtained from the patient to publish the material.
REFERENCES
- 1.
- 2.
- 3.